← Back to Search

Behavioural Intervention

Group 1: LEE for Post-Induction Hypotension

N/A
Waitlist Available
Led By Ranganathan Govindaraj, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* American Society of Anesthesiologists (ASA)3 or lower
* Patients requiring general anesthesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study (within 15 minutes of baseline)
Awards & highlights

Summary

The purpose of this study is to determine if lower extremity elevation (LEE) will reduce the incidence of postinduction hypotension, to compare the utilization of vasoactive medications after induction in patients with LEE and patients without LEE and to determine if LEE will increase measured cardiac output

Eligible Conditions
  • Post-Induction Hypotension

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study (within 15 minutes of baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study (within 15 minutes of baseline) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants that demonstrate hypotension
Secondary study objectives
Accumulated dose of rescue vasoactive agents
Change in heart rate
Change in non-invasive cardiac output
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1: LEEExperimental Treatment1 Intervention
Group II: Group 2: no LEEActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
932 Previous Clinical Trials
333,785 Total Patients Enrolled
Ranganathan Govindaraj, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
30 Total Patients Enrolled
~133 spots leftby Sep 2025